Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Perrigo Draws On OTC Strength For Private Label Nexium 24HR Launch

Executive Summary

Perrigo plans late September launch of a store brand OTC of Nexium 24HR after FDA’s ANDA approval and settlement of patent litigation with AstraZeneca. But it faces competition from Aurobindo's generic OTC esomeprazole 20 mg delayed-release capsules.

Advertisement

Related Content

Perrigo Glows From Mucinex Private Label Plan, Starboard Plug
Perrigo Glows From Mucinex Private Label Plan, Starboard Plug
Perrigo Glows From Mucinex Private Label Plan, Starboard Plug
Perrigo’s Outgoing CEO Advocates OTC Switches, Starting With Statins
Starboard Agreement Tilts Perrigo Toward Rx Generics Sale
Private Label Competition For Zegerid OTC Sets Sail With Perrigo Launch

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

PS121364

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel